Walleye Trading’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,000
| Closed | -$56.2K | – | 4649 |
|
|
2025
Q2 | $56.2K | Buy |
4,000
+3,000
| +300% | +$39.4K | ﹤0.01% | 3791 |
|
|
2025
Q1 | $13.5K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 3826 |
|
|
2024
Q2 | – | Sell |
-2,500
| Closed | -$95.8K | – | 4667 |
|
|
2024
Q1 | $95.8K | Sell |
2,500
-1,000
| -29% | -$48.4K | ﹤0.01% | 3789 |
|
|
2023
Q4 | $235K | Sell |
3,500
-6,100
| -64% | -$425K | ﹤0.01% | 3673 |
|
|
2023
Q3 | $719K | Buy |
9,600
+2,200
| +30% | +$195K | ﹤0.01% | 2636 |
|
|
2023
Q2 | $682K | Buy |
+7,400
| New | +$659K | ﹤0.01% | 2501 |
|
|
2023
Q1 | – | Sell |
-1,800
| Closed | -$208K | – | 5164 |
|
|
2022
Q4 | $208K | Sell |
1,800
-6,900
| -79% | -$803K | ﹤0.01% | 3545 |
|
|
2022
Q3 | $943K | Buy |
8,700
+6,500
| +295% | +$931K | ﹤0.01% | 2293 |
|
|
2022
Q2 | $397K | Buy |
+2,200
| New | +$394K | ﹤0.01% | 3111 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$21K | – | 5671 |
|
|
2021
Q4 | $21K | Sell |
100
-2,300
| -96% | -$475K | ﹤0.01% | 4917 |
|
|
2021
Q3 | $462K | Buy |
2,400
+1,300
| +118% | +$320K | ﹤0.01% | 2995 |
|
|
2021
Q2 | $311K | Sell |
1,100
-400
| -27% | -$108K | ﹤0.01% | 3447 |
|
|
2021
Q1 | $318K | Sell |
1,500
-5,000
| -77% | -$1.2M | ﹤0.01% | 3161 |
|
|
2020
Q4 | $1.28M | Buy |
6,500
+5,700
| +713% | +$1.01M | 0.01% | 1767 |
|
|
2020
Q3 | $132K | Sell |
800
-300
| -27% | -$49.4K | ﹤0.01% | 3251 |
|
|
2020
Q2 | $153K | Buy |
1,100
+700
| +175% | +$64.3K | ﹤0.01% | 3256 |
|
|
2020
Q1 | $25K | Sell |
400
-6,300
| -94% | -$574K | ﹤0.01% | 3590 |
|
|
2019
Q4 | $734K | Buy |
6,700
+3,200
| +91% | +$310K | 0.01% | 2072 |
|
|
2019
Q3 | $363K | Sell |
3,500
-7,000
| -67% | -$752K | ﹤0.01% | 2431 |
|
|
2019
Q2 | $1.35M | Buy |
10,500
+8,200
| +357% | +$1.14M | 0.01% | 1358 |
|
|
2019
Q1 | $293K | Sell |
2,300
-1,600
| -41% | -$203K | ﹤0.01% | 2717 |
|
|
2018
Q4 | $488K | Sell |
3,900
-1,000
| -20% | -$171K | ﹤0.01% | 2498 |
|
|
2018
Q3 | $1.09M | Buy |
4,900
+2,700
| +123% | +$547K | 0.01% | 1986 |
|
|
2018
Q2 | $352K | Buy |
+2,200
| New | +$281K | ﹤0.01% | 3155 |
|
|
2015
Q2 | – | Sell |
-100
| Closed | -$3K | – | 5018 |
|
|
2015
Q1 | $3K | Sell |
100
-1,000
| -91% | -$31.7K | ﹤0.01% | 3904 |
|
|
2014
Q4 | $37K | Buy |
+1,100
| New | +$34.3K | ﹤0.01% | 3375 |
|
Other funds holding MED
SCP
VCM
Walleye Trading's MED Position: Q1 2026 in Review
Walleye Trading opened a new position in Medifast (MED) in Q1 2026: 3,400 shares worth $34.6K. The stake represents ﹤0.01% of the portfolio and ranks #3766 among its holdings. This is a return to the name: Walleye Trading previously reported a position in MED as recently as Q3 2025.
Walleye Trading first reported a position in MED in Q4 2013 and has held it in 17 quarters since. The position peaked at $849K in Q3 2022. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Walleye Trading held 3,400 shares of Medifast worth $34.6K as of Q1 2026.
- Medifast was a new Walleye Trading position in Q1 2026.
- Medifast made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3766 holding.
- Walleye Trading first reported a position in Medifast in Q4 2013 and has held it in 17 quarters since.
- Walleye Trading's Medifast position peaked at $849K in Q3 2022.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.